Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Boundless Bio logo — Unbound by convention, bound to save lives

Boundless Bio

Unbound by convention, bound to save lives

Founded 2019 United States San Diego, United States 44 employees Series C Total: $251.40M Biotechnology, Health Care +2

General Information

Company Name Boundless Bio
Founded Year 2019
Location United States San Diego, United States
Employees 44
Industries Biotechnology, Health Care, Health and Wellness +1
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with Boundless Bio. To contact Boundless Bio, visit boundlessbio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Boundless Bio compare?

A PDF of Boundless Bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Boundless Bio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Boundless Bio

Boundless Bio, founded in 2018, is a biotechnology and healthcare startup based in the United States. The company's mission revolves around discovering and developing novel cancer therapeutics by focusing on the role of extrachromosomal DNA (ecDNA) in driving tumorigenesis, resistance, and recurrence. This groundbreaking approach targets the phenomenon of ecDNA, a pivotal factor in cancer cell growth and treatment resistance. The company's recent $100.00M Series C investment on 16 May 2023 demonstrates significant support from renowned investors, including Arch Venture Partners, RA Capital Management, Wellington Management, Alexandria Venture Investments, City Hill Ventures, Fidelity, Logos Capital, Nextech Invest, Piper Heartland Healthcare Capital, and Surveyor Capital. This substantial funding signifies confidence in Boundless Bio's innovative approach and potential for addressing unmet needs in cancer treatment. Boundless Bio's culture emphasizes a pioneering spirit and unwavering dedication to advancing cancer research and treatment. Their commitment to career development and collaborative teamwork underscores the company's holistic approach to driving progress in the field of oncology. With a powerful slogan, "Unbound by convention, bound to save lives," Boundless Bio encapsulates its relentless pursuit of impactful innovations in the fight against cancer.

Business keywords: cancer therapeutics, biopharma, extrachromosomal DNA, oncology, precision medicine, innovation, cancer treatment, drug development, career development, collaborative culture, unconventional approach, patient-focused, transformative therapies

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series C $100.00M 10
Arch Venture Partners RA Capital Management Wellington Management
Arch Venture Partners, RA Capital Management +8
16 May 2023
Series B $105.00M -
28 Apr 2021
Series A $46.40M -
19 Sep 2019

Boundless Bio Alternatives & Competitors

View All Alternatives
Boundless Bio vs
Fore Biotherapeutics
Fore Biotherapeutics United States

A precision oncology company rooted in science and innovation, developing cancer therapies guided by...

Series D
46 employees
Biotechnology, Health Care
Boundless Bio vs
Treeline
Treeline United States

Making medicines at the highest level

Series A
172 employees
Biotechnology, Health Care
Boundless Bio vs
Avelos Therapeutics
Avelos Therapeutics Korea South

Strive for a Better Tomorrow.

Series B
9 employees
Biotechnology, Life Sciences
View all alternatives

FAQ About Boundless Bio

Unbound by convention, bound to save lives
Boundless Bio was founded in 2019.
Boundless Bio is headquartered in San Diego, United States.
Boundless Bio operates in Biotechnology, Health Care, Health and Wellness and Life Sciences. Its work centres on cancer therapeutics, biopharma, extrachromosomal DNA and oncology.
Boundless Bio has approximately 44 employees.
Boundless Bio has completed 3 funding rounds, raising a total of $251.40M. The latest funding stage is Series C.
Top alternatives and competitors to Boundless Bio include Fore Biotherapeutics, Treeline, Avelos Therapeutics, Ikena Oncology (Merged with ImageneBio), Trethera. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Boundless Bio and Fore Biotherapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Boundless Bio, https://bouncewatch.com/company/boundless-bio, updated 9 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes